Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.55% | 73.74 | 0.9% | $598.99m | |
| CELG | Celgene Corporation | -0.84% | 129.19 | 1.1% | $425.21m | |
| AMGN | Amgen Inc. | -0.63% | 169.00 | 1.1% | $397.19m | |
| BIIB | Biogen Inc. | -1.42% | 282.64 | 1.2% | $346.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.31% | 477.15 | 2.7% | $319.17m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.43% | 153.25 | 1.9% | $227.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.83% | 135.67 | 1.9% | $211.59m | |
| ILMN | Illumina, Inc. | -0.59% | 193.62 | 3.5% | $208.34m | |
| KITE | Kite Pharma, Inc. | 1.63% | 138.17 | 16.1% | $135.10m | |
| INCY | Incyte Corporation | -0.17% | 123.65 | 2.6% | $130.04m | |
| CLVS | Clovis Oncology, Inc. | -0.68% | 71.61 | 18.0% | $125.25m | |
| TSRO | TESARO, Inc. | -0.18% | 120.40 | 14.7% | $124.85m | |
| A | Agilent Technologies, Inc. | -0.30% | 62.77 | 1.5% | $122.45m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.07% | 81.40 | 4.4% | $105.16m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.38% | 36.07 | 19.8% | $88.80m |
Company Profile
Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company focuses on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. It is in business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C. Esperion Therapeutics was founded by Roger S. Newton and Charles L. Bisgaier on January 22, 2008 and is headquartered in Ann Arbor, MI.